Year: 2010
Type: article
Abstract: In subjects with type 1 diabetes, autoimmune destruction of pancreatic �-cells leads eventually to an absolute requirement for insulin replacement therapy. Insulin delivered exogenously is not subject to normal physiological feedback regulation, so it may induce hypoglycemia even in the presence of an intact counterregulatory response. The average individual with type 1 diabetes experiences about two episodes of symptomatic hypoglycemia per week, a figure that has not changed substantially in the last 20 years (1). Severe hypoglycemia (requiring help for recovery) has an annual prevalence of 30–40 % and an annual incidence of 1.0 – 1.7 episodes per patient per year (1). This risk is increased markedly with the increasing duration of the disease and strict glycemic control. In subjects with type 2 diabetes,
Source: Diabetes
DOI: 10.2337/db10-0103
Authors: Rory J. McCrimmon, Robert S. Sherwin
Institutions: University of Dundee, Yale University
Language: Dutch
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W2124525693
